AusPAR: Trastuzumab

Australian Public Assessment Report

AusPAR

AusPAR: Trastuzumab [PDF, 499.79 KB]

AusPAR: Trastuzumab [Word, 340.5 KB]

AusPAR Attachment 1: Product Information for Trastuzumab [PDF, 462.32 KB]

AusPAR Attachment 1: Product Information for Trastuzumab [Word, 406.11 KB]

Device/Product Name

Ogivri

Active ingredients

Trastuzumab

AusPAR Date

18 March 2020

Published

20 March 2020

Submission Number

PM-2017-01084-1-4

Submission Type

Biosimilar

Decision

Approved